Please wait
Healthcare · Diagnostics & Research · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$26.8B
1.4%
25.77
Current price
$242.76
-0.8% 28 AugLast session 28 Aug · Checked 1d ago
Open
$244.67
Previous close
$244.61
Day range
$242.27 – $247.19
Volume
N/A
25.8x P/E
Awaiting filing
1.4% yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for DGX, with its range and direction at a glance.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Investors usually follow DGX for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 74/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$320M
TTM (2026-06-30)
ROE
14.6%
Return on equity
ROA
6.4%
Return on assets
Debt / equity
0.85
Lower is usually safer.
P/B ratio
3.55
Useful for book value support.
Dividend yield
1.4%
Current income signal.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price behavior and momentum still support follow-through.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
$244.31
Analyst view
None
Analyst target
$245.87
Forecast refresh
Updated 1d ago
Quality score
73
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.75
2025-01-14
Payment: TBA | Qualification: 2025-01-14 | Yield at declaration: N/A
$0.75
2024-10-04
Payment: TBA | Qualification: 2024-10-04 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+4.2% across the latest saved price window.
Volatility
Low
Beta is 0.55. Price has historically moved more calmly than the wider market.
52-week position
94% of range
Price is trading close to its 52-week high.
Volume confirmation
N/A
Comparable volume data is not available.
DGX
Quest Diagnostics Incorporated
Price: $242.76
P/E: 25.7707
Yield: 1.4%
ABBV
AbbVie Inc.
Price: $255.96
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.49
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.68
P/E: 27.310226
Yield: 0.0%
Industry
Diagnostics & Research
Employees
46000
Exchange
NYQ
Ticker
DGX
